Sebastian Kuger
Neuherberg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 20, 2018
Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
Journal: Cancer letters
Published: August 03, 2016
Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization.
Journal: Radiation oncology (London, England)
Published: July 29, 2015
Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines.
Journal: Radiation oncology (London, England)
Published: May 12, 2015
Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions.
Journal: Breast cancer : basic and clinical research
Published: November 21, 2013
Radiosensitization of Glioblastoma Cell Lines by the Dual PI3K and mTOR Inhibitor NVP-BEZ235 Depends on Drug-Irradiation Schedule.
Journal: Translational oncology
Published: October 22, 2012
Hsp90 inhibition by NVP-AUY922 and NVP-BEP800 decreases migration and invasion of irradiated normoxic and hypoxic tumor cell lines.
Journal: Cancer letters
Published: September 18, 2012
Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia.
Journal: Cancer biology & therapy
Published: January 31, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026